Showing results (1261-1270 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|August 1, 1990
Microbially controlled drug delivery to the colonA RubinsteinBiopharmaceutics & Drug Disposition|August 1, 1990
Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkeyF L Tse, H T Smith, F H Ballard, et al.Biopharmaceutics & Drug Disposition|May 3, 2018
Effect of single-walled carbon nanotubes on cytochrome P450 activity in human liver microsomes in vitroYuki Asai, Yukiko Sakakibara, Rina Inoue, et al.Biopharmaceutics & Drug Disposition|April 22, 1999
Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the ratH Sasabe, Y Kato, T Terasaki, et al.Biopharmaceutics & Drug Disposition|April 22, 1999
Pharmacokinetics of ethopropazine in the rat after oral and intravenous administrationM Maboudian-Esfahani, D R BrocksBiopharmaceutics & Drug Disposition|April 22, 1999
Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisonsD R Brocks, J W ToniBiopharmaceutics & Drug Disposition|March 23, 1999
Bioavailability of carbamazepine from four different products and the occurrence of side effectsM Olling, T T Mensinga, D M Barends, et al.Biopharmaceutics & Drug Disposition|March 23, 1999
Single- and multiple-dose pharmacokinetics of oral dolasetron and its active metabolites in healthy volunteers: part 2D C Dimmitt, Y S Choo, L A Martin, et al.Biopharmaceutics & Drug Disposition|April 17, 1999
Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosingA Corey, H Al-Khalidi, C Brezovic, et al.Biopharmaceutics & Drug Disposition|April 17, 1999
Serum protein binding of tolterodine and its major metabolites in humans and several animal speciesI Påhlman, P GozziPageof 214